JPMorgan cuts Pepsico stock price target on lower earnings outlook

JPMorgan cut its price target on PepsiCo to $172 from $176 and lowered 2026 EPS to $8.54 (from $8.64) and 2027 EPS to $8.97 (from $9.17); JPMorgan kept an Overweight rating and first-quarter 2026 organic sales and EPS at 2.5% and $1.55. The company announced a 5% quarterly dividend increase to $1.4225 (payable Mar 31, 2026; record Mar 6, 2026), maintaining a 53-year streak of raises and a 3.71% yield, while other analysts issued divergent targets (UBS $190 Buy, Piper Sandler $181, TD Cowen $162 Hold, BofA $173 Neutral). Shares trade around $153.21, below most targets, making this news relevant to stock-level positioning but unlikely to move the broader market.

Analysis

The market is treating the recent analyst churn as a near-term headline event rather than a regime shift; small EPS downgrades compress optionality around the earnings print but do not, in our view, alter PepsiCo’s structural cash-generation profile. Over the next 48–72 hours the dominant driver will be guidance/organic trends called out on the April 16 print; over 3–6 months the story becomes cadence of pricing vs volume and margin recovery as input cost pass-through and mix effects crystallize.

Second-order effects favor businesses with inelastic snack demand and stronger gross margin mix — think contract manufacturing and packaging suppliers that see steadier volumes from Frito-Lay versus aluminum can suppliers whose demand fluctuates with beverage volume. Currency and emerging-market reopenings remain low-frequency but high-impact levers: a modest FX tailwind in H2 would amplify EPS beats, while a renewed input-cost shock (oils, freight) would disproportionately compress snack margins after pricing lags.

Tail risks: a sharper-than-expected consumer slowdown or aggressive promotional response by peers would knock 8–12% off consensus EPS in 6–12 months; regulatory or sugar-tax headlines remain idiosyncratic catalysts that can compress multiples quickly. Conversely, confirmation of sustained volume recovery plus modest margin improvement would leave >20% upside to bullish street targets within 9–12 months given current valuation dispersion.

Contrarian read: the consensus is underweight the embedded optionality from capital return flexibility and portfolio skew toward higher-margin snacks. Instead of treating the name as a pure defensive dividend play, position size should reflect event risk around April results while leaning into a 6–12 month mean-reversion trade on margins and buyback optionality.

Key Decisions for Investors

• Tactical earnings hedge (days): Avoid owning naked stock into the April 16 print. If you want exposure, buy a 2–4 week OTM protective put (cost = insurance) sized to cover 3–5% NAV exposure; stop if IV collapses post-print and hedge cost >2% of position value.
• Directional options (3–6 months): Buy a 3–6 month bull-call spread to express upside while capping capital at risk (e.g., 155/185 spread equivalent). Target return 2.0–4.0x if PEP clears the upper strike; max loss = premium (plan for ~3–5% of notional).
• Relative-value pair (3–9 months): Long PEP / short KO sized to delta-neutral to isolate snack-driven margin re-rating. Rationale: PEP’s snack skew should outpace concentrate-led peers if commodity tailwinds persist; unwind if the pair diverges >8% intramonth.
• Income/roll down (quarterly cadence): If long shares for dividend capture, sell 1–3 month covered calls at a strike ~5–7% OTM to fund carry and lower basis. Exit or roll if the stock gaps >8% on positive print to avoid opportunity cost.
• Risk control: Trim or hedge exposure if management withdraws FY guide or if consensus EPS is cut >5% on the print — treat that as a regime change and reduce holdings to neutral until new cadence is confirmed.